Allen & Hanburys Ltd

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com
Summary of Product Characteristics last updated on the eMC: 20/07/2009
SPC Ventolin Evohaler

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/07/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.9 - Overdose
Updated on 25/09/2008 and displayed until 20/07/2009
Reasons for adding or updating:
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 10 date of revision of the text
Updated on 11/07/2007 and displayed until 25/09/2008
Reasons for adding or updating:
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 date of revision of the text
Updated on 16/03/2007 and displayed until 11/07/2007
Reasons for adding or updating:
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 10 date of revision of the text
Updated on 24/04/2006 and displayed until 16/03/2007
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 (date of (partial) revision of the text
Updated on 11/11/2005 and displayed until 24/04/2006
Reasons for adding or updating:
  • Change to section 4.2 - Posology and Method of Administration
Updated on 28/04/2005 and displayed until 11/11/2005
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Updated on 05/08/2003 and displayed until 28/04/2005
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 12/12/2002 and displayed until 05/08/2003
Reasons for adding or updating:
  • Removal of Black Triangle
Updated on 26/09/2002 and displayed until 12/12/2002
Reasons for adding or updating:
  • Removal of Black Triangle
Updated on 21/08/2001 and displayed until 26/09/2002
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 11/08/2001 and displayed until 21/08/2001
Reasons for adding or updating:
  • Transferred from eMC version 1
Updated on 18/09/2000 and displayed until 11/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 06/09/1999 and displayed until 18/09/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   salbutamol sulphate


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk